Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04864223 · ClinicalTrials.gov registry record
Classifying and Predicting Long-term Pain and Function in Older Adults
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 6,783
- Enrollment target
NCT04864223: Completed study, sponsored by University of Washington.
NCT04864223 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 6,783 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04864223 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 6,783 participants
- Enrollment target
Study Summary
This project will use novel methods to detect clinically meaningful subgroups of older adults based on long-term trajectories of bothersome pain and function. It will then identify older adults at high risk of experiencing poor long-term pain and function. Anticipated results will provide new insights into long-term patterns of pain and function across the aging process and identify potential predictors of each trajectory.
Primary Outcome
Question: "In the last month, have you been bothered by pain?" Dichotomous response of yes or no
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,783 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2020-07-31 |
What the finished NCT04864223 record still lists
NCT04864223 is an observational study that tracks outcomes without assigning an intervention. Its 6,783 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04864223 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04864223 about?
NCT04864223 is a clinical study titled "Classifying and Predicting Long-term Pain and Function in Older Adults". This project will use novel methods to detect clinically meaningful subgroups of older adults based on long-term trajectories of bothersome pain and function. It will then identify older adults at high risk of experiencing poor long-term pain and function. Anticipated results will provide new insigh...
What is the current status of trial NCT04864223?
This trial is currently completed. The enrollment target is 6,783 participants. The study started on 2018-08-01. Estimated completion is 2020-07-31.
Who is sponsoring clinical trial NCT04864223?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03887715 · 6,800 participants · NA
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- NCT06234384 · 6,833 participants
Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)
- NCT05121324 · 6,700 participants · Phase 3
Pediatric Dose Optimization for Seizures in Emergency Medical Services
- NCT06272045 · 6,618 participants · NA
Early Intervention to Promote Cardiovascular Health of Mothers and Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI